Logo image of PLAB

PHOTRONICS INC (PLAB) Stock Fundamental Analysis

USA - NASDAQ:PLAB - US7194051022 - Common Stock

23.2 USD
+1.38 (+6.32%)
Last: 10/13/2025, 8:00:00 PM
23.3 USD
+0.1 (+0.43%)
After Hours: 10/13/2025, 8:00:00 PM
Fundamental Rating

6

Overall PLAB gets a fundamental rating of 6 out of 10. We evaluated PLAB against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making PLAB a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on PLAB. This makes PLAB very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PLAB was profitable.
PLAB had a positive operating cash flow in the past year.
PLAB had positive earnings in each of the past 5 years.
Each year in the past 5 years PLAB had a positive operating cash flow.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

With a decent Return On Assets value of 6.19%, PLAB is doing good in the industry, outperforming 74.11% of the companies in the same industry.
PLAB has a Return On Equity of 9.64%. This is in the better half of the industry: PLAB outperforms 71.43% of its industry peers.
With a decent Return On Invested Capital value of 9.95%, PLAB is doing good in the industry, outperforming 78.57% of the companies in the same industry.
PLAB had an Average Return On Invested Capital over the past 3 years of 12.91%. This is in line with the industry average of 10.96%.
Industry RankSector Rank
ROA 6.19%
ROE 9.64%
ROIC 9.95%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

PLAB's Profit Margin of 12.67% is fine compared to the rest of the industry. PLAB outperforms 72.32% of its industry peers.
PLAB's Profit Margin has improved in the last couple of years.
The Operating Margin of PLAB (24.75%) is better than 83.04% of its industry peers.
PLAB's Operating Margin has improved in the last couple of years.
PLAB has a worse Gross Margin (35.81%) than 64.29% of its industry peers.
PLAB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.75%
PM (TTM) 12.67%
GM 35.81%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

PLAB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for PLAB has been increased compared to 1 year ago.
Compared to 5 years ago, PLAB has less shares outstanding
PLAB has a better debt/assets ratio than last year.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.16 indicates that PLAB is not in any danger for bankruptcy at the moment.
The Altman-Z score of PLAB (3.16) is comparable to the rest of the industry.
The Debt to FCF ratio of PLAB is 0.00, which is an excellent value as it means it would take PLAB, only 0.00 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.00, PLAB belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
The Debt to Equity ratio of PLAB (0.00) is better than 72.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.16
ROIC/WACC0.87
WACC11.49%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.99 indicates that PLAB has no problem at all paying its short term obligations.
PLAB's Current ratio of 4.99 is fine compared to the rest of the industry. PLAB outperforms 69.64% of its industry peers.
PLAB has a Quick Ratio of 4.62. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.62, PLAB is doing good in the industry, outperforming 77.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.99
Quick Ratio 4.62
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for PLAB have decreased by -4.27% in the last year.
PLAB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.90% yearly.
PLAB shows a decrease in Revenue. In the last year, the revenue decreased by -1.79%.
The Revenue has been growing by 9.50% on average over the past years. This is quite good.
EPS 1Y (TTM)-4.27%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%0%
Revenue 1Y (TTM)-1.79%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-0.28%

3.2 Future

Based on estimates for the next years, PLAB will show a small growth in Earnings Per Share. The EPS will grow by 3.14% on average per year.
PLAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.37% yearly.
EPS Next Y-3.08%
EPS Next 2Y1.66%
EPS Next 3Y3.14%
EPS Next 5YN/A
Revenue Next Year-2.73%
Revenue Next 2Y0.51%
Revenue Next 3Y2.37%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.49, which indicates a very decent valuation of PLAB.
Based on the Price/Earnings ratio, PLAB is valued cheaper than 99.11% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.35, PLAB is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.34, the valuation of PLAB can be described as very reasonable.
98.21% of the companies in the same industry are more expensive than PLAB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.86. PLAB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.49
Fwd PE 11.34
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

PLAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PLAB is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PLAB is valued cheaper than 87.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.24
EV/EBITDA 2.11
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.34
EPS Next 2Y1.66%
EPS Next 3Y3.14%

0

5. Dividend

5.1 Amount

PLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (10/13/2025, 8:00:00 PM)

After market: 23.3 +0.1 (+0.43%)

23.2

+1.38 (+6.32%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-27 2025-08-27/bmo
Earnings (Next)12-09 2025-12-09/bmo
Inst Owners94.71%
Inst Owner Change-0.07%
Ins Owners4.15%
Ins Owner Change0.35%
Market Cap1.37B
Analysts84.44
Price Target33.64 (45%)
Short Float %4.63%
Short Ratio3.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.28%
Min EPS beat(2)-19.14%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)8.06%
Min EPS beat(4)-19.14%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)2.53%
EPS beat(12)6
Avg EPS beat(12)2.1%
EPS beat(16)9
Avg EPS beat(16)6.98%
Revenue beat(2)1
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.62%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-2.81%
Revenue beat(12)4
Avg Revenue beat(12)-1.6%
Revenue beat(16)8
Avg Revenue beat(16)-0.57%
PT rev (1m)1.33%
PT rev (3m)5.66%
EPS NQ rev (1m)1.72%
EPS NQ rev (3m)9.12%
EPS NY rev (1m)9.66%
EPS NY rev (3m)9.66%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)-1.51%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 11.49
Fwd PE 11.34
P/S 1.6
P/FCF 21.24
P/OCF 5.99
P/B 1.22
P/tB 1.22
EV/EBITDA 2.11
EPS(TTM)2.02
EY8.71%
EPS(NY)2.05
Fwd EY8.82%
FCF(TTM)1.09
FCFY4.71%
OCF(TTM)3.87
OCFY16.68%
SpS14.51
BVpS19.08
TBVpS19.08
PEG (NY)N/A
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 6.19%
ROE 9.64%
ROCE 13.43%
ROIC 9.95%
ROICexc 15.68%
ROICexgc 15.68%
OM 24.75%
PM (TTM) 12.67%
GM 35.81%
FCFM 7.53%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 203.77%
Cap/Sales 19.14%
Interest Coverage 250
Cash Conversion 78.12%
Profit Quality 59.42%
Current Ratio 4.99
Quick Ratio 4.62
Altman-Z 3.16
F-Score5
WACC11.49%
ROIC/WACC0.87
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.27%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%0%
EPS Next Y-3.08%
EPS Next 2Y1.66%
EPS Next 3Y3.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.79%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-0.28%
Revenue Next Year-2.73%
Revenue Next 2Y0.51%
Revenue Next 3Y2.37%
Revenue Next 5YN/A
EBIT growth 1Y-8.07%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year26.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-50.42%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y-16.94%
OCF growth 3Y20.13%
OCF growth 5Y30.76%